-
Measuring Cancer Drug Response Beyond Viability
2026-09-24
Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central finding—that drugs can combine growth inhibition and cell killing in different proportions and on different timelines—supports using complementary measurements when interpreting in vitro experiments.
-
CUDC-907: Dual PI3K and HDAC Inhibitor Guide
2026-09-24
CUDC-907 is a dual PI3K and HDAC inhibitor for controlled cell-based studies of signaling, histone acetylation, cell-cycle progression, and apoptosis. This guide focuses on practical in vitro workflows; the compound is for scientific research only and is not intended for diagnostic, clinical, or therapeutic use.
-
Pertussis Toxin as a Gi/o Probe in DOM Models
2026-09-23
Pertussis toxin offers a way to test how Gi/o signaling shapes DOM-induced behavior, beyond its established use in immunology. This article interprets a 2024 mouse study to show why head-twitch and locomotor outcomes require separate mechanistic analysis—and where the toxin’s conclusions stop.
-
OCT2 and MATE1 Inhibition by 5-HT3 Antagonists
2026-09-23
The reference study systematically compared five 5-HT3 antagonist drugs for inhibition of renal OCT2- and MATE1-mediated transport using cellular uptake and transcellular secretion models. Its findings identify drug-specific differences in transporter inhibition and provide a mechanistic framework for evaluating possible renal drug–drug interactions involving cationic medicines.
-
UK-5099 for Mitochondrial Metabolism Research
2026-09-22
UK-5099 enables pathway-level testing of how mitochondrial pyruvate entry shapes immune-cell activation, respiration, and cytokine output. This practical guide combines standardized whole-blood stimulation with orthogonal metabolic controls, dose planning, and troubleshooting for more interpretable immunometabolism experiments.
-
Rimonabant (SR141716): Practical Research Workflows
2026-09-22
Rimonabant (SR141716) provides a selective CB1 antagonist framework for separating endocannabinoid signaling from nonspecific behavioral or cellular effects. This guide translates its receptor selectivity into practical workflows for withdrawal, appetite regulation research, inflammation, and assay troubleshooting.
-
Lactate as a Metabolic–Immune Control Point
2026-09-21
Lactate is not merely a glycolytic waste product. This translational perspective examines how L-lactate connects glycolytic flux, mitochondrial and hypoxic stress, and immune-checkpoint regulation through the NAT1–ENO1–TRAF6–PD-L1 axis in colorectal cancer research.
-
Valemetostat: EZH1/2 Workflows for Lymphoma Research
2026-09-21
Build cleaner lymphoma epigenetics experiments with Valemetostat (DS-3201), from EZH2 biochemical profiling to H3K27me3 and proliferation readouts. This workflow emphasizes mutant-aware assay design, exposure control, and troubleshooting for follicular lymphoma and diffuse large B-cell lymphoma research.
-
Benzyl-activated Streptavidin Magnetic Beads: K1301
2026-09-20
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) are approximately 3 μm streptavidin magnetic beads for capturing biotinylated proteins, nucleic acids, and other biomolecules. Their magnetic separation, BSA blocking formulation, and reported IgG capacity support adaptable purification and interaction workflows, while assay-specific validation remains necessary.
-
DiI (DiIC18(3)) Plasma Membrane Probe
2026-09-19
DiI (DiIC18(3)) is a lipophilic orange fluorescent probe for labeling plasma membranes in live or fixed cells and tissues, supporting neuronal tracing, migration, adhesion, fusion, and lipoprotein workflows. It is insoluble in water and should not be treated as a water-soluble stain or an organelle-specific intracellular marker.
-
Caspase-3 Colorimetric Assay Kit in Macrophage Research
2026-09-18
Translate macrophage stress phenotypes into a practical apoptosis readout with the Caspase-3 Colorimetric Assay Kit. Its DEVD-pNA signal supports rapid caspase activity measurement in plate-based workflows while helping researchers distinguish executioner-caspase activation from the inflammatory and bactericidal effects described in intestinal macrophages.
-
hUC-MSCs and the STMN2–SARM1 Axis in PND
2026-09-18
This study identifies a β-NGF-dependent STMN2/NMNAT2–SARM1–NF-κB pathway through which human umbilical cord mesenchymal stem cells reduce cognitive impairment after tibial fracture surgery in aged mice. Its combination of behavioral, pathological, proteomic, and pathway-intervention experiments links hUC-MSC treatment with reduced neuroinflammation, neuronal apoptosis, and dendritic degeneration.
-
Tigecycline: Glycylcycline Evidence & Workflows
2026-09-17
Tigecycline is a glycylcycline antibiotic and bacteriostatic 30S ribosomal subunit inhibitor with activity against several resistant Gram-positive and Gram-negative organisms. Its strongest evidence supports complicated skin and skin-structure infections and complicated intra-abdominal infections, while resistance-genotype studies require cautious interpretation.
-
Bobcat339 in DNA Methylation Research
2026-09-17
Bobcat339 provides a practical chemical perturbation for testing how TET1/TET2 activity influences DNA methylation, enhancer state, and osteogenic differentiation. This workflow pairs dose-response optimization with methylation, chromatin, transcriptional, and autophagy readouts instead of relying on a single endpoint.
-
Cy3-UTP Workflow for Fluorescent RNA
2026-09-16
Cy3-UTP enables bright, photostable RNA labeling for reconstitution assays, RNA-protein interaction studies, imaging, and detection. This workflow translates new insights into 28S rRNA expansion-segment multivalency into practical labeling, control, and troubleshooting choices.